The universal intravascular interventional surgery robot of Changhai Hospital has completed a number of "world's first", and 10 patients recovered well after six months of follow-up
New blood vessels
2022NVM neovascularizationSuccessfully held on 2-4 June. During the conference, many domestic vascular surgery experts expounded their new ideas for the future of vascular surgery.Professor Lu Qingsheng, Department of Vascular Surgery, Shanghai Changhai HospitalAlso introduced to us at the conference partial surgical case of a new universal endovascular interventional surgery robot.Recently, we received good news from the organizers of the conference that the robot has passed a single-center clinical trial and completed a six-month follow-up.
Although the surgical robot was born in 1969, the vascular surgical robot developed abroad and domestic imitation still has some limitations : it cannot solve the application of commercialized guide wire, catheter, balloon and stent; It can not complete all the steps of endovascular interventional surgery. Can not be used in aortic, peripheral vascular and other vascular diseases. Since the beginning of 2010, Shanghai Changhai Hospital has been committed to the research and development of a new universal endovascular interventional surgery robot, which is suitable for a variety of commercial endovascular instruments and can be used for all kinds of endovascular interventional surgery and complete the whole procedure.
On January 16, 2022, professor qing-sheng lu ascular surgery, changhai hospital took the lead team to complete the the friends of medical intervention surgery robot intracavitary ALLVAS ᵀ ᴹ single-center trials that marks this with Chinese intellectual property rights of a new type of universal intracavitary interventional surgery robot can enter the new era of multi-center clinical trial.
Endovascular repair of aortic aneurysm
Up to now, more than half a year of follow-up, the five patients with aneurysms had no postoperative discomfort such as abdominal pain, and the reexamination imaging showed that there was no endorrhea in the stent position, and the false lumen of aneurysms was gradually thrombolized.
PTA stenting of lower extremity arteries
From November 7, 2021 to January 16, 2022, five patients with lower extremity arteriosclerosis and occlusion were enrolled. Professor Lu Qingsheng's team took the lead in the completion of the world's first 5 cases of lower extremity artery PTA stenting assisted by a new universal endovascular interventional surgery robot in the whole process . The results showed that the stent was completely released during the operation, and the recanalization rate of the occluded artery of the lower extremity was 100%.
Five patients were followed up for more than half a year after the operation. The symptoms were significantly improved, and the blood flow in the stent was unobstructed without occlusion.
Endovascular interventional surgery robot is a symbol of the beginning of the era of precision intelligent minimally invasive endovascular surgery. In order to adapt to the development trend, it is necessary to realize robot automation and intelligence, the overall automation of endovascular interventional surgery room, and the endovascular instruments to adapt to the change of automation. Shanghai Changhai Hospital for vascular three-dimensional navigation + automatic & LDquo; Driving & throughout; The full automation study has had preliminary results. We believe that in the near future, a new, safer, more stable and more intelligent, universal endovascular interventional surgery robot will replace or even surpass the operator to complete complex and difficult clinical needs.
Surgical robot,Endovascular intervention